Category: Latest News

  • Xeris Biopharma shares rise nearly 3% after Q4 earnings beat and strong 2026 outlook

    Xeris Biopharma shares rise nearly 3% after Q4 earnings beat and strong 2026 outlook

    Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) shares gained nearly 3% in premarket trading on Monday after the company reported fourth-quarter results that topped analyst expectations and issued 2026 revenue guidance above consensus forecasts. The biopharmaceutical company posted adjusted earnings per share of $0.06 for the fourth quarter, exceeding analyst estimates of $0.02 by $0.04. Quarterly revenue…

  • Sealed Air tops Q4 forecasts on stronger revenue and earnings performance

    Sealed Air tops Q4 forecasts on stronger revenue and earnings performance

    Sealed Air Corporation (NYSE:SEE) reported fourth-quarter results on Monday that came in ahead of analyst expectations, with both revenue and earnings exceeding consensus forecasts. The company posted adjusted earnings per share of $0.77, surpassing the analyst estimate of $0.73. Shares were little changed following the announcement, edging up 0.05% in premarket trading. Quarterly revenue totaled…

  • Astrana Health shares rise more than 3% after earnings beat and upbeat outlook

    Astrana Health shares rise more than 3% after earnings beat and upbeat outlook

    Astrana Health, Inc. (NASDAQ:ASTH) shares gained over 3% in premarket trading on Monday after the healthcare management company reported fourth-quarter results that surpassed analyst expectations and pointed to continued growth momentum heading into 2026. The company posted adjusted earnings per share of $0.54 for the fourth quarter, significantly exceeding the analyst consensus forecast of $0.10…

  • uniQure shares plunge 45% after FDA setback on Huntington’s gene therapy

    uniQure shares plunge 45% after FDA setback on Huntington’s gene therapy

    Shares of uniQure N.V. (NASDAQ:QURE) dropped 45% on Monday after the company revealed that the U.S. Food and Drug Administration declined to support its proposed regulatory pathway for the approval of AMT-130, an experimental gene therapy targeting Huntington’s disease. According to final minutes from a Type A meeting held on January 30, the FDA said…

  • Yatsen shares slide 12% after fourth-quarter earnings miss expectations

    Yatsen shares slide 12% after fourth-quarter earnings miss expectations

    Yatsen Holding Limited (NYSE:YSG) shares fell nearly 12% in premarket trading on Monday after the China-based beauty company reported fourth-quarter results that came in below earnings expectations. The company posted adjusted earnings per ADS of $0.07 for the quarter, missing analyst forecasts despite delivering improved profitability compared with the prior year. Fourth-quarter revenue rose 20.1%…

  • Venture Global shares jump 7% after fourth-quarter earnings surpass expectations

    Venture Global shares jump 7% after fourth-quarter earnings surpass expectations

    Venture Global, Inc. (NYSE:VG) shares surged 7% in premarket trading on Monday after the liquefied natural gas exporter reported fourth-quarter results that exceeded profit forecasts, supported by a sharp increase in production volumes. The company posted adjusted earnings per share of $0.41 for the fourth quarter, ahead of analyst estimates of $0.35. Quarterly revenue totaled…

  • Norwegian Cruise Line slides after soft 2026 outlook despite Q4 earnings beat

    Norwegian Cruise Line slides after soft 2026 outlook despite Q4 earnings beat

    Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) shares fell 7.8% in premarket trading after the company delivered stronger-than-expected fourth-quarter earnings but disappointed investors with weaker revenue and fiscal 2026 guidance that came in below market forecasts. The cruise operator reported adjusted earnings per share of $0.28 for the fourth quarter, ahead of analyst expectations of $0.26.…

  • RadNet shares gain 3% following $270 million acquisition of AI firm Gleamer

    RadNet shares gain 3% following $270 million acquisition of AI firm Gleamer

    RadNet Inc (NASDAQ:RDNT) shares rose 3% to $71.91 in premarket trading on Monday after the U.S.-based imaging services provider announced plans to acquire French radiology artificial intelligence company Gleamer in an all-cash deal valued at up to €230 million ($270 million). The transaction will position RadNet’s DeepHealth division as the largest global supplier of clinical…

  • Energy stocks advance as oil prices surge amid Middle East tensions

    Energy stocks advance as oil prices surge amid Middle East tensions

    Shares of U.S. energy companies moved higher in premarket trading on Monday, tracking a sharp rise in crude oil prices following an escalation of conflict in the Middle East. Brent crude futures jumped as much as 13% to $82.37 per barrel — their highest level since January 2025 — before easing back to $79.39 per…

  • Shipping stocks climb over 4% as Strait of Hormuz disruptions redirect vessel traffic

    Shipping stocks climb over 4% as Strait of Hormuz disruptions redirect vessel traffic

    Shares in major container shipping operators, including A.P. Møller Maersk (USOTC:AMKBY) and Hapag Lloyd (USOTC:HPGLY), advanced more than 4% on Monday after Iran-related disruptions in the Strait of Hormuz prompted several carriers to halt vessel transits through the critical waterway. The developments also supported energy markets, with Brent and U.S. crude futures rising more than…